TrialNature medicine2025

Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial.

Jeff Skinner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.